TY - JOUR
T1 - Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies
T2 - Design and Methodological Aspects
AU - on behalf of the Panel for the IFSO-EC on the Surgical Treatment of Obesity Using Multimodal Strategies
AU - De Luca, Maurizio
AU - Belluzzi, Amanda
AU - Salminen, Paulina
AU - Bueter, Marco
AU - Pujol-Rafols, Juan
AU - Sakran, Nasser
AU - Stier, Christine
AU - Taskin, Halit Eren
AU - Chiappetta, Sonja
AU - Carrano, Francesco Maria
AU - Di Lorenzo, Nicola
AU - Nienhuijs, Simon
AU - Puy, Ramón Vilallonga
AU - Stenberg, Erik
AU - Emous, Marloes
AU - Prager, Gerhard
AU - Himpens, Jacques
AU - Felsenreich, Daniel Moritz
AU - Iannelli, Antonio
AU - Parmar, Chetan
AU - Copaescu, Catalin
AU - Fried, Martin
AU - Ruiz-Úcar, Elena
AU - Cohen, Ricardo V.
AU - Olmi, Stefano
AU - Angrisani, Luigi
AU - Ribeiro, Rui
AU - Bandini, Giulia
AU - Scoccimarro, Daniele
AU - Ragghianti, Benedetta
AU - Monami, Matteo
N1 - Publisher Copyright:
© 2024 by the authors.
PY - 2024/8/28
Y1 - 2024/8/28
N2 - Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. Results: These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m2 who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. Conclusions: The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.
AB - Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. Results: These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m2 who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. Conclusions: The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.
KW - endoscopic weight loss procedures
KW - guidelines
KW - lifestyle interventions
KW - metabolic bariatric surgery
KW - obesity
KW - obesity management medications
KW - obesity-related medical conditions
UR - http://www.scopus.com/inward/record.url?scp=85204120713&partnerID=8YFLogxK
U2 - 10.3390/jcm13175106
DO - 10.3390/jcm13175106
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39274320
AN - SCOPUS:85204120713
SN - 2077-0383
VL - 13
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
IS - 17
M1 - 5106
ER -